Irisin and Carcinoembryonic Antigen (CEA) as Potential Diagnostic Biomarkers in Gastric and Colorectal Cancers
- 1 November 2021
- journal article
- research article
- Published by CMV Verlag in Reports of Biochemistry and Molecular Biology
- Vol. 10 (3) , 488-494
Abstract
Carcinoembryonic antigen (CEA) is a common gastrointestinal tumor biomarker. Irisin is adipo-myokines that has been suggested to have a potential role in cancer development. However, limited studies test irisin as biomarker in gastric and colorectal cancers. Therefore, this study aims to investigate whether CEA and irisin could be a potential diagnostic biomarker in gastric and colorectal cancer. A case-control study consists of 90 subjects, 21 gastric cancer patients, 49 colorectal cancer patients and 20 control. Serum CEA was detected by fluorescence immunoassay (FIA) kit. Serum irisin was determined by enzyme-linked immunosorbent assay (ELISA) kit. Serum CEA increases significantly and serum irisin decreases significantly in gastric and colorectal cancer patients. According to Receiver Operating Characteristic (ROC) curve analysis, in gastric cancer, the area under curve of CEA is 1.00 (95% CI, 1.000-1.000, p< 0.0001). The diagnostic cut-off of CEA is< 3.08 ng/ml with %100 sensitivity and 100% specificity. The area under curve of irisin is 0.94 (95% CI, 0.8177-1.000, p< 0.0001). The cut-off of irisin is> 30.2 ng/ml with %90 sensitivity and 100%, specificity. In colorectal cancer, the area under curve of CEA is 0.99 (95% CI, 0.9866-1.000, p< 0.0001) and the diagnostic value< 2.6 ng/ml with %98 sensitivity and %100 specificity. The area under curve of irisin is 0.96 (95% CI, 0.9155-1.000, p< 0.0001). The diagnostic cut-off of irisin is> 41.9 ng/ml with 88.1sensitivity and 90.5 specificity. CEA and irisin could be powerful potential diagnostic biomarkers which would be use for early detection of gastric and colorectal cancers.Keywords
This publication has 26 references indexed in Scilit:
- Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristicsBMC Cancer, 2015
- Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast CancerPLOS ONE, 2015
- Effects of the exercise‐inducible myokine irisin on malignant and non‐malignant breast epithelial cell behavior in vitroInternational Journal of Cancer, 2014
- Association of Serum Irisin with Metabolic Syndrome in Obese Chinese AdultsPLOS ONE, 2014
- Circulating Irisin in Relation to Insulin Resistance and the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- Decrease in Irisin in Patients with Chronic Kidney DiseasePLOS ONE, 2013
- FNDC5/Irisin Is Not Only a Myokine but Also an AdipokinePLOS ONE, 2013
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancerJournal of Surgical Oncology, 2010
- Prognostic Effect of Perioperative Change of Serum Carcinoembryonic Antigen Level: A Useful Tool for Detection of Systemic Recurrence in Rectal CancerAnnals of Surgical Oncology, 2006